author-photo

Ilse Van Hove

Johnson & Johnson Pharmaceutical Research and Development

16

Papers

1039

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Erratum: Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (Translational psychiatry (2019) 9 1 (216))

2019 Translational Psychiatry
Show All
- Source
- Cite
- Save
Citations (1)
Letter to the editor Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain

2014
Show All
- Source
- Cite
- Save
Citations (0)
Original article Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

2013
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.

2010 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (217)
Osteoarthritis [119–126]119. The Value of HFE Genotyping in Exceptional Osteoarthritis

2010 Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Poster 52: Health-related Outcomes of Tapentadol Extended Release Treatment for Chronic Low Back Pain

2009 Pm&r
Show All
- Source
- Cite
- Save
Citations (0)
Poster 66: Tapentadol Extended Release for the Relief of Chronic Pain Associated With Osteoarthritis of the Knee: Assessment of Opioid Withdrawal From a Randomized, Active- and Placebo-controlled Study

2009 Pm&r
Show All
- Source
- Cite
- Save
Citations (0)
Poster 48: Gastrointestinal Tolerability of Tapentadol Extended Release in Patients With Chronic Low Back Pain: Results of a Randomized, Double-blind, Active- and Placebo-controlled Phase 3 Study

2009 Pm&r
Show All
- Source
- Cite
- Save
Citations (3)
188. Gastrointestinal Tolerability of Tapentadol Extended Release Treatment for Chronic Low Back Pain

2009 The Spine Journal
Show All
- Source
- Cite
- Save
Citations (0)
P141. Tapentadol Extended Release vs. Oxycodone Controlled Release for Treating Moderate to Severe Chronic Low Back Pain: Study Discontinuations from a Randomized, Double-Blind Phase 3 Trial

2009 The Spine Journal
Show All
- Source
- Cite
- Save
Citations (0)